Cargando…
Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy
SIMPLE SUMMARY: This review is intended to provide an overview on the history and recent advances of T cell and natural killer (NK) cell-based immunotherapy. While the thymus was discovered as the origin of T cells in the 1960s, and NK cells were first described in 1975, the clinical application of...
Autores principales: | Wendel, Philipp, Reindl, Lisa Marie, Bexte, Tobias, Künnemeyer, Leander, Särchen, Vinzenz, Albinger, Nawid, Mackensen, Andreas, Rettinger, Eva, Bopp, Tobias, Ullrich, Evelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004685/ https://www.ncbi.nlm.nih.gov/pubmed/33807011 http://dx.doi.org/10.3390/cancers13061481 |
Ejemplares similares
-
Immunotherapy with NK cells: recent developments in gene modification open up new avenues
por: Reindl, Lisa Marie, et al.
Publicado: (2020) -
P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
por: Albinger, Nawid, et al.
Publicado: (2023) -
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
por: Albinger, Nawid, et al.
Publicado: (2021) -
Unleashing the power of NK cells in anticancer immunotherapy
por: Vogler, Meike, et al.
Publicado: (2021) -
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
por: Bexte, Tobias, et al.
Publicado: (2022)